Who
Arthur Kuan
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, CG Oncology.
In numbers
- Trades disclosed
- 16
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 4 Oct 2024
- Last trade
- 15 Apr 2026
- Last filed
- 16 Apr 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Apr 2026filed 16 Apr 2026 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —271,600 at $0.00 | filing |
| 15 Apr 2026filed 16 Apr 2026 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —271,600 at $0.00 | filing |
| 12 Mar 2026filed 13 Mar 2026 | CGON CG OncologyBiotechnology | SEC FORM 4 Code M | $111K64,612 at $1.72 | filing |
| 12 Mar 2026filed 13 Mar 2026 | CGON CG OncologyBiotechnology | SEC FORM 4 Code F | $111K1,847 at $60.15 | filing |
| 12 Mar 2026filed 13 Mar 2026 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code M | —64,612 at $0.00 | filing |
| 12 Mar 2026filed 13 Mar 2026 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code M | —64,612 at $0.00 | filing |
| 12 Mar 2026filed 13 Mar 2026 | CGON CG OncologyBiotechnology | SEC FORM 4 Code M | $111K64,612 at $1.72 | filing |
| 12 Mar 2026filed 13 Mar 2026 | CGON CG OncologyBiotechnology | SEC FORM 4 Code F | $111K1,847 at $60.15 | filing |
| 4 Mar 2026filed 6 Mar 2026 | CGON CG OncologyBiotechnology | SEC FORM 4 Code M | $177K102,871 at $1.72 | filing |
| 4 Mar 2026filed 6 Mar 2026 | CGON CG OncologyBiotechnology | SEC FORM 4 Code F | $177K2,871 at $61.61 | filing |
| 4 Mar 2026filed 6 Mar 2026 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code M | —102,871 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code M | —102,871 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | CGON CG OncologyBiotechnology | SEC FORM 4 Code M | $177K102,871 at $1.72 | filing |
| 4 Mar 2026filed 6 Mar 2026 | CGON CG OncologyBiotechnology | SEC FORM 4 Code F | $177K2,871 at $61.61 | filing |
| 15 Apr 2025filed 16 Apr 2025 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —527,660 at $0.00 | filing |
| 4 Oct 2024filed 7 Oct 2024 | CGON CG Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —397,800 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.